Clinical Trial

Superior Parietal iTBS for PD-MCI

Name: Superior Parietal iTBS for PD-MCI — clinical trial record (NCT07701785)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this study is to determine the whether a short-term, high-dose form of non-invasive brain stimulation (intermittent theta burst stimulation; iTBS) is a promising and safe treatment for mild cognitive impairment in Parkinson's disease (PD-MCI).

Trial Details

NCT Number	NCT07701785
Lead Sponsor	Medical University of South Carolina Collaborators: National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS)
Conditions	Parkinson Disease, Mild Cognitive Impairment
Enrollment	30 participants
Start Date	2026-08-01
Primary Completion	2028-02-01 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-14